99 related articles for article (PubMed ID: 20649532)
1. Neuroprotective mechanisms of brain-derived neurotrophic factor against 3-nitropropionic acid toxicity: therapeutic implications for Huntington's disease.
Wu CL; Hwang CS; Chen SD; Yin JH; Yang DI
Ann N Y Acad Sci; 2010 Jul; 1201():8-12. PubMed ID: 20649532
[TBL] [Abstract][Full Text] [Related]
2. Protective effects of brain-derived neurotrophic factor against neurotoxicity of 3-nitropropionic acid in rat cortical neurons.
Wu CL; Hwang CS; Yang DI
Neurotoxicology; 2009 Jul; 30(4):718-26. PubMed ID: 19428112
[TBL] [Abstract][Full Text] [Related]
3. Sonic hedgehog mediates BDNF-induced neuroprotection against mitochondrial inhibitor 3-nitropropionic acid.
Wu CL; Chen SD; Hwang CS; Yang DI
Biochem Biophys Res Commun; 2009 Jul; 385(1):112-7. PubMed ID: 19422804
[TBL] [Abstract][Full Text] [Related]
4. Metabolic profiling of 3-nitropropionic acid early-stage Huntington's disease rat model using gas chromatography time-of-flight mass spectrometry.
Chang KL; New LS; Mal M; Goh CW; Aw CC; Browne ER; Chan EC
J Proteome Res; 2011 Apr; 10(4):2079-87. PubMed ID: 21355552
[TBL] [Abstract][Full Text] [Related]
5. Protective effect of hesperidin and naringin against 3-nitropropionic acid induced Huntington's like symptoms in rats: possible role of nitric oxide.
Kumar P; Kumar A
Behav Brain Res; 2010 Jan; 206(1):38-46. PubMed ID: 19716383
[TBL] [Abstract][Full Text] [Related]
6. IGF-1 exacerbates the neurotoxicity of the mitochondrial inhibitor 3NP in rats.
Escartin C; Boyer F; Bemelmans AP; Hantraye P; Brouillet E
Neurosci Lett; 2007 Oct; 425(3):167-72. PubMed ID: 17868993
[TBL] [Abstract][Full Text] [Related]
7. Novel protective mechanisms of antidepressants against 3-nitropropionic acid induced Huntington's-like symptoms: a comparative study.
Kumar P; Kalonia H; Kumar A
J Psychopharmacol; 2011 Oct; 25(10):1399-411. PubMed ID: 20305041
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotective effect of taurine in 3-nitropropionic acid-induced experimental animal model of Huntington's disease phenotype.
Tadros MG; Khalifa AE; Abdel-Naim AB; Arafa HM
Pharmacol Biochem Behav; 2005 Nov; 82(3):574-82. PubMed ID: 16337998
[TBL] [Abstract][Full Text] [Related]
9. Cytochrome c oxidase isoform IV-2 is involved in 3-nitropropionic acid-induced toxicity in striatal astrocytes.
Singh S; Misiak M; Beyer C; Arnold S
Glia; 2009 Nov; 57(14):1480-91. PubMed ID: 19306371
[TBL] [Abstract][Full Text] [Related]
10. Atorvastatin attenuates mitochondrial toxin-induced striatal degeneration, with decreasing iNOS/c-Jun levels and activating ERK/Akt pathways.
Lee ST; Chu K; Park JE; Hong NH; Im WS; Kang L; Han Z; Jung KH; Kim MW; Kim M
J Neurochem; 2008 Mar; 104(5):1190-200. PubMed ID: 17976163
[TBL] [Abstract][Full Text] [Related]
11. Protective effect of minocycline, a semi-synthetic second-generation tetracycline against 3-nitropropionic acid (3-NP)-induced neurotoxicity.
Ahuja M; Bishnoi M; Chopra K
Toxicology; 2008 Feb; 244(2-3):111-22. PubMed ID: 18164115
[TBL] [Abstract][Full Text] [Related]
12. Discriminative behavioral assessment unveils remarkable reactive astrocytosis and early molecular correlates in basal ganglia of 3-nitropropionic acid subchronic treated rats.
Cirillo G; Maggio N; Bianco MR; Vollono C; Sellitti S; Papa M
Neurochem Int; 2010 Jan; 56(1):152-60. PubMed ID: 19799953
[TBL] [Abstract][Full Text] [Related]
13. A bile acid protects against motor and cognitive deficits and reduces striatal degeneration in the 3-nitropropionic acid model of Huntington's disease.
Keene CD; Rodrigues CM; Eich T; Linehan-Stieers C; Abt A; Kren BT; Steer CJ; Low WC
Exp Neurol; 2001 Oct; 171(2):351-60. PubMed ID: 11573988
[TBL] [Abstract][Full Text] [Related]
14. Protective effect of rivastigmine against 3-nitropropionic acid-induced Huntington's disease like symptoms: possible behavioural, biochemical and cellular alterations.
Kumar P; Kumar A
Eur J Pharmacol; 2009 Aug; 615(1-3):91-101. PubMed ID: 19445928
[TBL] [Abstract][Full Text] [Related]
15. BDNF regulates BIM expression levels in 3-nitropropionic acid-treated cortical neurons.
Almeida S; Laço M; Cunha-Oliveira T; Oliveira CR; Rego AC
Neurobiol Dis; 2009 Sep; 35(3):448-56. PubMed ID: 19555760
[TBL] [Abstract][Full Text] [Related]
16. Granulocyte-colony stimulating factor attenuates striatal degeneration with activating survival pathways in 3-nitropropionic acid model of Huntington's disease.
Lee ST; Park JE; Kim DH; Kim S; Im WS; Kang L; Jung SH; Kim MW; Chu K; Kim M
Brain Res; 2008 Feb; 1194():130-7. PubMed ID: 18166168
[TBL] [Abstract][Full Text] [Related]
17. Potential role of TrkB agonist in neuronal survival by promoting CREB/BDNF and PI3K/Akt signaling in vitro and in vivo model of 3-nitropropionic acid (3-NP)-induced neuronal death.
Ahmed S; Kwatra M; Gawali B; Panda SR; Naidu VGM
Apoptosis; 2021 Feb; 26(1-2):52-70. PubMed ID: 33226552
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of 3-nitropropionic acid-induced membrane permeability transition of isolated mitochondria and its suppression by L-carnitine.
Nishimura M; Okimura Y; Fujita H; Yano H; Lee J; Suzaki E; Inoue M; Utsumi K; Sasaki J
Cell Biochem Funct; 2008 Dec; 26(8):881-91. PubMed ID: 18942062
[TBL] [Abstract][Full Text] [Related]
19. Erythropoietin and sonic hedgehog mediate the neuroprotective effects of brain-derived neurotrophic factor against mitochondrial inhibition.
Wu CL; Chen SD; Yin JH; Hwang CS; Yang DI
Neurobiol Dis; 2010 Oct; 40(1):146-54. PubMed ID: 20580927
[TBL] [Abstract][Full Text] [Related]
20. Blood level of brain-derived neurotrophic factor mRNA is progressively reduced in rodent models of Huntington's disease: restoration by the neuroprotective compound CEP-1347.
Conforti P; Ramos C; Apostol BL; Simmons DA; Nguyen HP; Riess O; Thompson LM; Zuccato C; Cattaneo E
Mol Cell Neurosci; 2008 Sep; 39(1):1-7. PubMed ID: 18571429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
